4//SEC Filing
Kelley Kenneth J 4
Accession 0001179110-20-005379
CIK 0001159036other
Filed
Apr 30, 8:00 PM ET
Accepted
May 1, 7:12 PM ET
Size
4.9 KB
Accession
0001179110-20-005379
Insider Transaction Report
Form 4
Kelley Kenneth J
Director
Transactions
- Award
Common Stock
2020-04-30+8,829→ 286,382 total
Footnotes (1)
- [F1]Represents annual restricted stock grant under the Issuer's director compensation program. This grant will vest in full on the earlier of (i) April 30, 2021 or (ii) the date of the Issuer's next annual meeting of stockholders.
Documents
Issuer
HALOZYME THERAPEUTICS, INC.
CIK 0001159036
Entity typeother
Related Parties
1- filerCIK 0001291219
Filing Metadata
- Form type
- 4
- Filed
- Apr 30, 8:00 PM ET
- Accepted
- May 1, 7:12 PM ET
- Size
- 4.9 KB